AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32799180 — intervention group
Group type: EXPERIMENTAL
Intervention: European size 38 clogs (US male size 6½, US female size 7½)
Number of subjects: 50
Study 32799180 — intervention group
Group type: COMPARATOR
Intervention: European size 47 clogs (US male size 13½, US female size 14½)
Number of subjects: 50
Study 35145209 — intervention group
Group type: EXPERIMENTAL
Intervention: High loading dose caffeine (80 mg/kg)
Number of subjects: 74
Study 35145209 — intervention group
Group type: COMPARATOR
Intervention: Standard loading dose caffeine (20 mg/kg)
Number of subjects: 74
Study 33715788 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic pressure (IP) with traditional treatment
Number of subjects: 45
Study 33715788 — intervention group
Group type: EXPERIMENTAL
Intervention: Postisometric relaxation (PIR) with traditional treatment
Number of subjects: 45
Study 33715788 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment
Number of subjects: 45
Study 32929337 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrophage‐biomimetic nanomedicine loaded with rosiglitazone, specific targeting to inflammatory colon, and ROS-responsive release mechanism.
Number of subjects: 0
Study 32929337 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified, but implied standard treatment for UC.
Number of subjects: 0
Study 36432574 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinoa-enriched wheat-bread roll providing 20 g quinoa flour each day
Number of subjects: 28
Study 36432574 — intervention group
Group type: COMPARATOR
Intervention: Control wheat-only bread roll
Number of subjects: 28
Study 34439234 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (10 treatments within five weeks)
Number of subjects: 52
Study 34439234 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation plus insomnia advice booklet (single session)
Number of subjects: 52
Study 33172720 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab with concomitant topical corticosteroids
Number of subjects: 0
Study 33172720 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35932644 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Activate intervention
Number of subjects: 37
Study 35932644 — intervention group
Group type: COMPARATOR
Intervention: Comparison cohort (initiating methadone treatment alone)
Number of subjects: 37
Study 32584511 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinistral portal hypertension (SPH) in patients with CP
Number of subjects: 3358
Study 32584511 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for SPH
Number of subjects: 3358
Study 32584511 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrointestinal bleeding in patients with SPH
Number of subjects: 3358
Study 32584511 — intervention group
Group type: COMPARATOR
Intervention: Comparison between bleeding and non-bleeding groups
Number of subjects: 3358
Study 33730397 — intervention group
Group type: EXPERIMENTAL
Intervention: in‐vivo behavioral skills training (BST)
Number of subjects: 60
Study 33730397 — intervention group
Group type: EXPERIMENTAL
Intervention: interactive computer training (ICT)
Number of subjects: 60
Study 33730397 — intervention group
Group type: COMPARATOR
Intervention: video model
Number of subjects: 60
Study 32506368 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS program
Number of subjects: 65
Study 32506368 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 65
Study 34621373 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine patients (83)
Number of subjects: 171
Study 34621373 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-migraine patients)
Number of subjects: 171
Study 32015261 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.45 mg/d oral conjugated equine estrogens (o-CEE)
Number of subjects: 467
Study 32015261 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mcg/d transdermal 17β-estradiol (t-E2)
Number of subjects: 467
Study 32015261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 467
Study 36373731 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 48
Study 36373731 — intervention group
Group type: COMPARATOR
Intervention: Sensory-motor training
Number of subjects: 48
Study 34092819 — intervention group
Group type: EXPERIMENTAL
Intervention: KIOS software system for managing bipolar disorder
Number of subjects: 20
Study 33220690 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-lesional glucantime plus 50% trichloroacetic acid (TCA)
Number of subjects: 150
Study 33220690 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-lesional glucantime
Number of subjects: 150
Study 33220690 — intervention group
Group type: COMPARATOR
Intervention: Systemic glucantime
Number of subjects: 150
Study 36121699 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline spiritual well-being
Number of subjects: 242
Study 36121699 — intervention group
Group type: EXPERIMENTAL
Intervention: Increases in spiritual well-being
Number of subjects: 242
Study 36121699 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreases in spiritual well-being
Number of subjects: 242
Study 36121699 — intervention group
Group type: EXPERIMENTAL
Intervention: Marital status (married vs non-married)
Number of subjects: 242
Study 34184997 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital self-management support tools (DSMSTs)
Number of subjects: 0
Study 35838863 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-pulsed 755-nm alexandrite laser
Number of subjects: 22
Study 34114407 — intervention group
Group type: EXPERIMENTAL
Intervention: Herb-partitioned moxibustion (HPM)
Number of subjects: 63
Study 36193494 — intervention group
Group type: EXPERIMENTAL
Intervention: Best Medical Therapy (BMT) combined with Thoracic Endovascular Aortic Repair (TEVAR)
Number of subjects: 90
Study 36193494 — intervention group
Group type: COMPARATOR
Intervention: Control group (BMT only)
Number of subjects: 90
Study 32500194 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular facet steroid injection (IFSI)
Number of subjects: 56
Study 32500194 — intervention group
Group type: EXPERIMENTAL
Intervention: Transforaminal steroid injection (TFSI)
Number of subjects: 56
Study 35451239 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact for 30 minutes after birth
Number of subjects: 68
Study 35451239 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 68
Study 32648476 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based advance directive (AD)
Number of subjects: 91
Study 32648476 — intervention group
Group type: COMPARATOR
Intervention: Paper advance directive (AD)
Number of subjects: 91
Study 32243719 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple intake (acute intervention, short-term intervention, free-living cohort study)
Number of subjects: 0
Study 32243719 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple intake (dose-response study)
Number of subjects: 0
Study 32243719 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary xylose (free-living cohort)
Number of subjects: 0
Study 32243719 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary xylose
Number of subjects: 0
Study 32243719 — intervention group
Group type: COMPARATOR
Intervention: Control food - broccoli
Number of subjects: 0
Study 36419383 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhiyang Pingfu Liquid combined with minocycline and methylprednisolone for 14 days
Number of subjects: 58
Study 36419383 — intervention group
Group type: COMPARATOR
Intervention: Placebo liquid combined with minocycline and methylprednisolone for 14 days
Number of subjects: 58
Study 36419383 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhiyang Pingfu Liquid
Number of subjects: 58
Study 36419383 — intervention group
Group type: COMPARATOR
Intervention: Placebo liquid
Number of subjects: 58
Study 35111046 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose GHX02 (1920 mg/day)
Number of subjects: 117
Study 35111046 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose GHX02 (960 mg/day)
Number of subjects: 117
Study 35111046 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 35111046 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose GHX02
Number of subjects: 117
Study 35111046 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose GHX02 and Standard-dose GHX02
Number of subjects: 117
Study 35111046 — intervention group
Group type: EXPERIMENTAL
Intervention: All GHX02 groups
Number of subjects: 117
Study 34116214 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEK interbody lordotic spacers
Number of subjects: 138
Study 34116214 — intervention group
Group type: COMPARATOR
Intervention: Cortical allograft
Number of subjects: 138
Study 33866196 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard PD therapy
Number of subjects: 106
Study 35883143 — intervention group
Group type: EXPERIMENTAL
Intervention: APPLE Tree intervention
Number of subjects: 704
Study 35883143 — intervention group
Group type: COMPARATOR
Intervention: Control arm (dementia prevention information)
Number of subjects: 704
Study 33882774 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-guided percutaneous microwave ablation (MWA)
Number of subjects: 234
Study 32466676 — intervention group
Group type: EXPERIMENTAL
Intervention: MiStent sirolimus-eluting stent
Number of subjects: 1398
Study 32466676 — intervention group
Group type: COMPARATOR
Intervention: Xience everolimus-eluting stent
Number of subjects: 1398
Study 35419610 — intervention group
Group type: COMPARATOR
Intervention: No Manipulation under anesthesia (no-MUA)
Number of subjects: 391
Study 35419610 — intervention group
Group type: EXPERIMENTAL
Intervention: MUA patients
Number of subjects: 391
Study 33244634 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0
Study 35923135 — intervention group
Group type: EXPERIMENTAL
Intervention: EBP leadership immersion intervention (Cohort 2020)
Number of subjects: 66
Study 35923135 — intervention group
Group type: EXPERIMENTAL
Intervention: EBP leadership immersion intervention (Cohort 2021)
Number of subjects: 66
Study 32033271 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention via a web-based platform
Number of subjects: 463
Study 32033271 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 463
Study 34348564 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pharmacist intervention
Number of subjects: 93
Study 34348564 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 93
Study 36472545 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncology nurse-led primary palliative care intervention (CONNECT)
Number of subjects: 235
Study 34153117 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg once monthly
Number of subjects: 261
Study 34153117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 261
Study 32897933 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg prednisolone per day for 1 week
Number of subjects: 93
Study 32897933 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 35985784 — intervention group
Group type: EXPERIMENTAL
Intervention: Single hamstring tendon graft
Number of subjects: 100
Study 35985784 — intervention group
Group type: COMPARATOR
Intervention: Double hamstring tendon graft
Number of subjects: 100
Study 34593709 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient portal use
Number of subjects: 1081
Study 32770969 — intervention group
Group type: EXPERIMENTAL
Intervention: Take a Stand! intervention
Number of subjects: 0
Study 36179790 — intervention group
Group type: EXPERIMENTAL
Intervention: 120-second MicroPulse Transscleral Laser Therapy (MPTLT)
Number of subjects: 19
Study 36179790 — intervention group
Group type: COMPARATOR
Intervention: 100-second MicroPulse Transscleral Laser Therapy (MPTLT)
Number of subjects: 19
Study 33073871 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-effects regression model based on the hurdle version of the Poisson-Lindley distribution
Number of subjects: 0
Study 33073871 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian approach based on the Adaptive Metropolis algorithm
Number of subjects: 0
Study 33073871 — intervention group
Group type: EXPERIMENTAL
Intervention: Monte Carlo simulation studies
Number of subjects: 0
Study 33073871 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity analysis based on standard divergence measures
Number of subjects: 0
Study 33073871 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian p-value and randomized quantile residuals
Number of subjects: 0
Study 32576247 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized tonotopical fitting of a cochlear implant (CI) based on post-operative cone beam CT scan (CBCT)
Number of subjects: 20
Study 32576247 — intervention group
Group type: COMPARATOR
Intervention: Standard fitting program
Number of subjects: 20
Study 35193802 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional acupressure
Number of subjects: 140
Study 35193802 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm acupressure
Number of subjects: 140
Study 35193802 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold acupressure
Number of subjects: 140
Study 35193802 — intervention group
Group type: COMPARATOR
Intervention: No acupressure (Control)
Number of subjects: 140
Study 34656227 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (240 mg every 2 weeks)
Number of subjects: 332
Study 34656227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study 32344430 — intervention group
Group type: EXPERIMENTAL
Intervention: Unhealthy drinking habits (binge drinking and excessive consumption)
Number of subjects: 8500
Study 32344430 — intervention group
Group type: EXPERIMENTAL
Intervention: Trends in smoking and alcohol consumption
Number of subjects: 8500
Study 36341778 — intervention group
Group type: EXPERIMENTAL
Intervention: Education provided by rheumatologists
Number of subjects: 102
Study 36341778 — intervention group
Group type: COMPARATOR
Intervention: Education provided by nurse specialists
Number of subjects: 102
Study 36341778 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple switches of bsDMARDs
Number of subjects: 102
Study 36341778 — intervention group
Group type: EXPERIMENTAL
Intervention: Switching from adalimumab bsDMARDs GP2017 to MSB 11022
Number of subjects: 102
Study 36341778 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge assessment of bsDMARDs
Number of subjects: 102
Study 35974020 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic yogurt containing Pediococcus acidilactici GR-1
Number of subjects: 152
Study 35974020 — intervention group
Group type: COMPARATOR
Intervention: Conventional yogurt
Number of subjects: 152
Study 33653126 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleft‐Customized Occlusal Rating system
Number of subjects: 31
Study 34774080 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese medicine JCM-16021
Number of subjects: 392
Study 34774080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392
Study 34486432 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise at 70% of arterial occlusion pressure (high group)
Number of subjects: 25
Study 34486432 — intervention group
Group type: COMPARATOR
Intervention: No blood flow restriction exercise (control group)
Number of subjects: 25
Study 34486432 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise at 40% of arterial occlusion pressure (low group)
Number of subjects: 25
Study 35438677 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy + Kinesiotaping (KT)
Number of subjects: 50
Study 35438677 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 50
Study 33866940 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% body mass (BM) shank-positioned wearable resistance (WR)
Number of subjects: 15
Study 33866940 — intervention group
Group type: COMPARATOR
Intervention: No load (control)
Number of subjects: 15
Study 34923564 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaesthesia Nociception Index monitoring
Number of subjects: 93
Study 34923564 — intervention group
Group type: COMPARATOR
Intervention: Standard monitoring
Number of subjects: 93
Study 34923564 — intervention group
Group type: EXPERIMENTAL
Intervention: Narcotrend monitoring
Number of subjects: 93
Study 33359603 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 17
Study 33359603 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 17
Study 616597587 — intervention group
Group type: EXPERIMENTAL
Intervention: Body image lessons (6 hours)
Number of subjects: 144
Study 616597587 — intervention group
Group type: COMPARATOR
Intervention: Control group (lessons as normal)
Number of subjects: 144
Study 35298338 — intervention group
Group type: EXPERIMENTAL
Intervention: Technical assistance provided to previously trained producers
Number of subjects: 0
Study 35298338 — intervention group
Group type: EXPERIMENTAL
Intervention: ABC Cerrado program investment
Number of subjects: 0
Study 35926833 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal (IN) trivalent modified-live virus (MLV) respiratory vaccine with parenteral (PT) bivalent bovine viral diarrhea virus (BVDV) type I + II vaccine (INT)
Number of subjects: 525
Study 35926833 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral (PT) pentavalent modified-live virus (MLV) respiratory vaccine (INJ)
Number of subjects: 525
Study 35926833 — intervention group
Group type: COMPARATOR
Intervention: No MLV respiratory vaccination (CON)
Number of subjects: 525
Study 35926833 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal (IN) trivalent modified-live virus (MLV) respiratory vaccine with parenteral (PT) BVDV type I + II vaccine (INT)
Number of subjects: 525
Study 32013965 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health applications with high usability problems (based on heuristic evaluation)
Number of subjects: 30
Study 32013965 — intervention group
Group type: EXPERIMENTAL
Intervention: Heuristic evaluation of mobile health applications
Number of subjects: 30
Study 32405975 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex (2 or 4 mg·kg‐1)
Number of subjects: 62
Study 32405975 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine (70 µg·kg‐1, maximum 5 mg)
Number of subjects: 62
Study 33025447 — intervention group
Group type: EXPERIMENTAL
Intervention: Free pharmaceutical services provided in public hospitals
Number of subjects: 797
Study 33556292 — intervention group
Group type: EXPERIMENTAL
Intervention: Count of all comorbidities
Number of subjects: 0
Study 33556292 — intervention group
Group type: EXPERIMENTAL
Intervention: Count of self-management intensive conditions (diabetes, hypertension, congestive heart failure)
Number of subjects: 0
Study 33952546 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (60 mg/kg/day of DHA)
Number of subjects: 955
Study 33952546 — intervention group
Group type: COMPARATOR
Intervention: Control emulsion (placebo)
Number of subjects: 955
Study 33072714 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking in an urban quiet 'green' district (quiet residential area with front gardens and street trees)
Number of subjects: 11
Study 33072714 — intervention group
Group type: COMPARATOR
Intervention: Walking in an urban busy 'gray' district (busy, built up commercial street)
Number of subjects: 11
Study 35605529 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone (BUP‐NX)
Number of subjects: 570
Study 35605529 — intervention group
Group type: COMPARATOR
Intervention: Extended-release naltrexone (XR‐NTX)
Number of subjects: 570
Study 33184717 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic Activation (SA)
Number of subjects: 110
Study 33184717 — intervention group
Group type: COMPARATOR
Intervention: No Sonic Activation (NSA)
Number of subjects: 110
Study 33491385 — intervention group
Group type: EXPERIMENTAL
Intervention: Single application of 1% NaF-HF gel
Number of subjects: 986
Study 33491385 — intervention group
Group type: EXPERIMENTAL
Intervention: Two applications of 1% NaF-HF gel with a 7-day interval
Number of subjects: 986
Study 33491385 — intervention group
Group type: EXPERIMENTAL
Intervention: Two applications of 1% NaF-HF gel with a 6-month interval
Number of subjects: 986
Study 33491385 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 986
Study 32297937 — intervention group
Group type: EXPERIMENTAL
Intervention: Galactose (0.75 g/kg body mass) in a high-fat beverage
Number of subjects: 19
Study 32297937 — intervention group
Group type: COMPARATOR
Intervention: Glucose (0.75 g/kg body mass) in a high-fat beverage
Number of subjects: 19
Study 32297937 — intervention group
Group type: COMPARATOR
Intervention: Fructose (0.75 g/kg body mass) in a high-fat beverage
Number of subjects: 19
Study 33196511 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulation and atorvastatin 40 mg daily
Number of subjects: 21
Study 33196511 — intervention group
Group type: COMPARATOR
Intervention: Anticoagulation alone (with either warfarin or rivaroxaban)
Number of subjects: 21
Study 34534253 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-up (walking on a treadmill) followed by a fatiguing exercise (modified sit-to-stand)
Number of subjects: 17
Study 34534253 — intervention group
Group type: COMPARATOR
Intervention: Control session (sitting on a chair)
Number of subjects: 17
Study 33050072 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (fish oil emulsion)
Number of subjects: 58
Study 33050072 — intervention group
Group type: COMPARATOR
Intervention: Omega-6 fatty acids (sunflower oil emulsion)
Number of subjects: 58
Study 34431329 — intervention group
Group type: EXPERIMENTAL
Intervention: Real pulsed radiofrequency (PRF) of the saphenous nerve
Number of subjects: 16
Study 34431329 — intervention group
Group type: COMPARATOR
Intervention: Sham pulsed radiofrequency (PRF) of the saphenous nerve
Number of subjects: 16
Study 34058488 — intervention group
Group type: EXPERIMENTAL
Intervention: HOBSCOTCH (n=31)
Number of subjects: 51
Study 34058488 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual control (n=20)
Number of subjects: 51
Study 32423235 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music during milking sessions (two sessions of 15 minutes each at 11:00 and 16:00)
Number of subjects: 40
Study 32423235 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music during milking sessions
Number of subjects: 40
Study 32423235 — intervention group
Group type: COMPARATOR
Intervention: Milking without music (control group)
Number of subjects: 40